Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
- 13 September 2003
- journal article
- Published by Elsevier BV in Molecular Brain Research
- Vol. 118 (1-2), 140-146
- https://doi.org/10.1016/j.molbrainres.2003.08.005
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Identification of proteins in human cerebrospinal fluid using liquid‐phase isoelectric focusing as a prefractionation step followed by two‐dimensional gel electrophoresis and matrix‐assisted laser desorption/ionisation mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Studies of potential cerebrospinal fluid molecular markers for Alzheimer's diseaseElectrophoresis, 2002
- Analysis of the human lumbar cerebrospinal fluid proteomeElectrophoresis, 2002
- Proteome analysis of cerebrospinal fluid proteins in Alzheimer patientsNeuroReport, 2002
- Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse ModelNeurobiology of Disease, 2000
- Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆Neurobiology of Aging, 2000
- Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in SwedenNeuroepidemiology, 1999
- α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimerʼs diseaseNeuroReport, 1992
- Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in ratNeuron, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984